Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir +/- Ribavirin in Chronic Genotype 1 HCV (LONESTAR)
NCT01726517Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Oct 2012; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01726517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726517.